Bioruptor Plus sonication device

Closed Pre-Solicitation Posted

Solicitation number
75N91024Q00106
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Maryland 20892, United States

Notice details come from SAM.gov. Updated .

About this opportunity

Paragraph 1:

The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Laboratory of Biochemistry and Molecular Biology (LBMB) in the Center for Cancer Research (CCR) plans to procure a Bioruptor Plus sonication device on a sole source basis from Diagenode, Inc. The device is required to replace an existing broken unit, and the LBMB has concluded that the Bioruptor Plus is the only device capable of meeting their specific research requirements, particularly regarding the required power level for chromatin shearing. The acquisition will be processed under FAR Part 12 for Commercial Items and is exempt from the requirements of FAR Part 6. Responses to this notice must be submitted by 12:00 P.M. EST on June 12, 2024.

Paragraph 2:

This procurement does not have a set-aside designation. Diagenode, Inc. is the sole source provider as the manufacturer of the Bioruptor Plus device. The value of the procurement is not specified, but the device is required for the LBMB's research activities. Interested parties, especially small businesses, are invited to submit capability statements or quotes for the government's consideration, though the agency reserves the right to proceed with the sole source acquisition based on its determination.

Notice text

The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), ), Laboratory of Biochemistry and Molecular Biology (LBMB) in the Center for Cancer Research (CCR) plans to procure, on a sole source basis, Bioruptor Plus sonication device from:

Diagenode, Inc,
400 Morris Avenue, 
Suite 101, Denville, NJ 07834

The response close date of the notice for this requirement is in accordance with FAR 5.203(b). This acquisition will be processed under FAR Part 12 – Acquisition for Commercial Items and will be made pursuant to the authority in FAR Part 13.106-1 (b)(1) and is exempt from the requirements of FAR Part 6. The North American Industry Classification System code is 334516 and the business size standard is 1000 employees. 

A replacement device is being requested for LBMB’s broken Bioruptor Plus sonication device. LBMB market research reveals it is not possible to utilize another platform/device and achieve adequate results consistent with past performance. The NCI has spent time and effort optimizing techniques and protocols of use of the instrument, which makes it not possible to utilize another device and obtain satisfactory results. Several features of the Bioruptor are critical to meet LBMB research requirements, in particular the power level achieved using the Bioruptor cannot be met by competing devices and is required for chromatin shearing of fission yeast. From discussion with colleagues, internet research, on site demonstrations, and discussions with company representatives, LBMB has concluded that no other company or small business can provide a similar device capable of achieving similar or adequate results. This equipment is manufactured solely through Diagenode and is not available through other vendors. Thus, market research concludes that there are currently no other companies that can competitively offer this device.

This notice is not a request for competitive quotations. However, if any interested party, especially a small business, believes it can meet the Government’s needs, it may submit a capability statement, proposal, or quote for the Government to consider. The response and any other information furnished must be in writing and must contain sufficient details to allow NCI to determine if the party can perform the requirement. Responses to this notice shall be submitted via email to Contract Specialist David Romley at David.Romley@nih.gov no later than 12:00 P.M. EST on Wednesday, June 12, 2024 (6/12/2024). A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered for the purpose of determining whether to conduct a competitive procurement. The Government reserves the right to use the information provided by respondents for any purpose deemed necessary and legally appropriate. To receive an award, Contractors must be registered and have valid certification through SAM.GOV. Please reference the notice number 75N91024Q00106 on all correspondence. 

***Please reference attached Statement of Need for more details pertaining to the nature of the work to be performed.***
 

Files

File Type Posted
SON - Bioruptor Plus - NOI SS.docx DOCX document
NOI Sole Source - Bioruptor Plus.docx DOCX document

Similar open opportunities

Opportunity Agency Set-aside Responses due
Intent to Sole Source - Medical/Scientific Instruments for the Department of Transfusion Medicine, NIH Clinical Center Bethesda, Maryland 20892, United States · NAICS 334516 National Institutes of Health No set-aside
Intent to Sole Source - BD FACSCanto II instrument Bethesda, Maryland 20892, United States · NAICS 334516 National Institutes of Health No set-aside
Service agreement for the cytena f sight cell sorter Bethesda, Maryland 20892, United States · NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside
Notice of Intent to Sole Source – AB Sciex LLC Maryland 20892, United States · NAICS 339112 NIH Clinical Center No set-aside
Service Maintenance for MoFlo Astrio AW10012 Bethesda, Maryland 20892, United States · NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity